Press release
📈 Stocks
📊 Neutral
🌍 Ireland
Neuromod Appoints Joe Ghiz as Chief Commercial Officer to Lead Global Sales
Neuromod taps industry veteran Joe Ghiz as Chief Commercial Officer to accelerate the global rollout and commercial adoption of its Lenire tinnitus treatment technology.
Impact
10/10
💡 Key Takeaways
- Joe Ghiz joins Neuromod to oversee global commercial operations and sales strategy.
- The appointment aims to scale the market presence of the Lenire tinnitus treatment device.
📋 Executive Summary
Neuromod Devices has appointed Joe Ghiz as its new Chief Commercial Officer to spearhead the company's global sales strategy. Ghiz will focus on expanding market access for Lenire, the company's flagship tinnitus treatment device, leveraging his extensive background in global commercial leadership.
📊 Sentiment Analysis
Sentiment
📊 Neutral
Impact Score
10/10
Region
🌍 Ireland
Asset Class
📈 Stocks
❓ Frequently Asked Questions
Joe Ghiz is tasked with leading the global sales strategy and expanding access to the Lenire tinnitus treatment device.
📰 Source
📅 Originally published:
⚠️ Disclaimer: This content is for training purposes only and should not be considered financial advice. Always conduct your own research before making investment decisions.